Solera Health, a Phoenix, AZ-based technology-enabled integrated benefit network has raised $42 million in Series C funding led by HCSC Ventures. Current investors BlueCross BlueShield Venture Partners/Sandbox Advantage Fund, Adams Street Partners and SJF Ventures also participated in the most recent funding round. The Series C round, Solera's largest to date, brings its total funding to $72 million.Integrated Benefit NetworkFounded in 2015, Solera Health serves as an integrated benefit network
Read More
Digital Therapeutics | Digital Health | Evidence-Based Therapeutics Interventions
Fitbit Health Solutions Business Grew 70%, $30.5M in Revenue in Q1 2019
Fitbit today released its Q1 2019 earnings reporting revenue of $272 million, GAAP net loss per share of $(0.31), non-GAAP net loss per share of $(0.15), GAAP net loss of $(79) million, non-GAAP net loss of $(38) million, cash flow from operations of $(68) million and free cash flow of $(74) million.Q1 2019 Fitbit Health Solutions EarningsFitbit Health Solutions business grew 70% YOY with revenue of $30.5M, which was an important contributing factor to the company’s positive momentum overall in
Read More
Validic Integrates With Welldoc’s Bluestar Platform to Enable Real-Time Insights for Patients
Validic, a provider of data solutions for remote monitoring and virtual engagement is integrating with Welldoc’s BlueStar platform. The integration of personal health data within the Welldoc BlueStar digital therapeutic platform will allow users to connect their wearables, apps, and in-home health devices directly to the platform – enabling deeper engagement and better self-management of one's health.The Power of Leveraging Device-Generated Data for PatientsAs the number of people managing
Read More
Israeli-based OurCrowd Launches $50M Medtech Fund
OurCrowd, an Israeli-based global investment platform has announced the launch of the $50 million OurCrowd Medtech Fund. The $50M fund will focus exclusively on investing in disruptive medical technologies and therapeutics with the potential to transform global healthcare delivery and patient outcomes. The announcement marks OurCrowd's first fund dedicated to the medical technology market. OurCrowd vets and selects companies invests its own capital and invites its accredited membership of
Read More
AdoRx Therapeutics, J&J Team Up to Develop Novel Lung Cancer Therapeutics
AdoRx Therapeutics, a UK based drug discovery company, and Johnson & Johnson are teaming up to develop novel therapeutics for the treatment of lung cancer. As part of the strategic collaboration, AdoRx has granted an exclusive option to research, develop and commercialize novel antagonists within the AdoRx portfolio, and the groups will collaborate on drug discovery and preclinical development activities. AdoRx Therapeutics is pursuing the discovery of new therapeutics for cancer-based on
Read More
Propeller Health: 84% of People with Asthma May Be Using Their Inhaler Incorrectly
The vast majority of people with asthma may be using their inhalers incorrectly, potentially making their medicine less effective and increasing their risk of asthma attacks, according to new research published in The Journal of Allergy and Clinical Immunology. Traditionally, asthma medicines require that patients take two "puffs" of their inhaler to receive the prescribed dose. Recommended Asthma Inhaler GuidelinesAsthma guidelines and patient instructions for inhaled medications recommend that
Read More
Cognoa Awarded FDA Breakthrough Designations for Diagnostic and Digital Therapeutic Devices for Autism
Cognoa, a digital health company focused on behavioral health for children, today announced FDA Breakthrough designations for it's first diagnostic and therapeutic devices to identify and treat autism. This is the foundation for its AI-based digital precision health to support the developmental and behavioral health of children, combining diagnostics and therapeutics into one platform. This signifies a big step in the company’s expansion into therapeutics.FDA Breakthrough Devices Program
Read More
Big Health Launches Digital Therapeutics App, Daylight to Improve Anxiety
Daylight is the first digital therapeutic to combine cognitive behavioral therapy, animation and the human voice to help people improve feelings of worry and anxiety. Digital therapeutics company Big Health today announced the launch of Daylight™, a scientifically rigorous yet approachable mobile app for reducing feelings of worry and anxiety. The Daylight app uses scientifically proven techniques based on cognitive behavioral therapy (CBT) to address feelings of worry and anxiety wherever and
Read More
M&A Analysis: 10 Reasons Why ResMed Acquired Propeller Health for $225M
On December 3rd, ResMed announced the acquisition of digital therapeutics maker Propeller Health for $225 million to help establish itself as a leader in COPD management across all stages of the disease. Digital medicines can help to personalize treatments, monitor patients in real-time, detect day-to-day changes in disease condition and increase patient adherence. Founded in 2010, Propeller helps people and their doctors better manage their COPD and asthma. Propeller’s digital medicine platform
Read More
ResMed to Acquire Propeller Health for $225M, Will Operate as Standalone Business
ResMed to acquire digital therapeutics maker Propeller Health for $225 million, establishing itself as a leader in COPD management.ResMed, a provider of cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, today announced it has entered a definitive agreement to acquire digital therapeutics startup Propeller Health for $225M. For ResMed, the acquisition will help establish the company as a leader in COPD management across all stages of the
Read More
